Intellectual property ranks among the most important assets of any life sciences or technology company, particularly start-ups and maturing companies in these sectors. Not only do IP rights protect a company’s most critical products, but they also facilitate the development of new products through proprietary research platforms. In addition, the development and licensing of intellectual property has important tax implications for companies, including start-ups. This is particularly true of companies engaging in cross-border licensing and/or research collaborations with affiliates or third parties.
Please join Michael Lebovitz, Co-Leader of Mayer Brown’s International Tax practice, and James Ferguson, Mayer Brown Intellectual Property partner, as they discuss the following topics:
- How to best protect your company’s IP Portfolio through the placement and licensing of IP assets
- How to use your IP portfolio to develop new innovations, either internally or through licensing collaborations with third parties
- How to draft employee agreements to ensure corporate ownership of the innovations developed by employees
- How to best design your IP licensing structure to protect enforcement options for your company’s IP portfolio
- How to optimize your company’s tax position through the placement and licensing of its IP assets
- The tax and IP issues that can arise when your company moves the ownership of its IP assets from one affiliate to another affiliate in a different jurisdiction
Also learn more about our firm’s focus on Israel.
CLE is not available when viewing a recording of this program. In order to receive credit you must have attended the live webinar program.